Patent application title:

METHODS AND COMPOSITIONS OF INSECT CONTROL

Publication number:

US20210127683A1

Publication date:
Application number:

17/075,440

Filed date:

2020-10-20

Abstract:

The invention describes recombinant DNA sequences transcribed into RNA constructs capable of forming Virus Like Particles (VLPs) suitable for insect control applications.

Inventors:

Assignee:

Interested in similar patents?

Get notified when new applications in this technology area are published.

Classification:

C12N15/1131 »  CPC further

Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides against viruses

C12N2795/18023 »  CPC further

Bacteriophages; Details ssRNA Bacteriophages positive-sense Virus like particles [VLP]

C12N2310/14 »  CPC further

Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.

C12N2770/00042 »  CPC further

ssRNA viruses positive-sense; Details; Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule

C12N2795/16023 »  CPC further

Bacteriophages; Details ssRNA Bacteriophages negative-sense Virus like particles [VLP]

A01N63/00 »  CPC main

Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates

C07K14/005 »  CPC further

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses

C12N15/113 »  CPC further

Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

C12N15/70 »  CPC further

Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression Vectors or expression systems specially adapted for E. coli

C12N15/81 »  CPC further

Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression; Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts

Description

CROSS REFERENCE TO RELATED APPLICATIONS

This application claims priority from U.S. application Ser. No. 16/062,097, filed Jun. 13, 2018, which is a National Stage Entry of PCT Application No. PCT/US2016/065408, filed Dec. 7, 2016, which claims priority from U.S. Provisional Application No. 62/273,654, filed Dec. 31, 2015, the contents of all of which are incorporated herein by reference in their entirety.

INCORPORATION OF SEQUENCE LISTING

The entire contents of a paper copy of the “Sequence Listing” and a computer readable form of the sequence listing entitled Insect Control Sequence Listing ST25.txt, which is 30 kilobytes in size and was created on Dec. 7, 2016, are herein incorporated by reference.

FIELD OF THE INVENTION

The invention comprises methods and compositions relating to virus-like particles (VLPs) containing heterologous cargo molecules capable of generating an RNAi-mediated gene suppression effect on targeted insects. Such compositions and methods have application in crop protection and other aspects of insect control.

BACKGROUND OF THE INVENTION

RNAi-mediated gene suppression, first described in the nematode C. elegans, has been shown to be an effective method for modulating gene expression in many other organisms. Fire et al., Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806 (1998). The role of RNAi in controlling proliferation of insects affecting crops has been demonstrated using double-stranded RNA (dsRNA) by a number of research groups. Reviewed in, Ivashuta, et al. Environmental RNAi in herbivorous insects. RNA 21:840 (2015). Recombinant RNA constructs used for RNAi purposes described in the prior art generally consist of dsRNAs of about 18 to about 25 base pairs (siRNAs), but also include longer dsRNAs (long dsRNAs) usually between about 100 to about 1,000 base pairs (bp). To successfully introduce dsRNA into insects, dsRNAs longer than or equal to approximately 60 bp are required for efficient uptake when supplied in the insect's diet. Bolognesi, et al. Ultrastructural Changes Caused by Snf7 RNAi in Larval Enterocytes of Western Corn Rootworm (Diabrotica virgifera virgifera Le Conte) PLoS One 7:e47534 (2012). Long dsRNA molecules are cleaved in-vivo into a diverse population of siRNAs by the host's Dicer enzyme complex. Alternatively, RNAi gene suppression can also occur through the action of anti-sense RNAs directed to specific sequences via related processes. Practical application of RNAi methods for controlling insects in the field is limited by the cost of in vitro RNA synthesis and the chemical fragility of RNA, even dsRNAs, to environmental and enzymatic degradation.

Bacteriophage MS2 capsid mediated delivery of toxins and imaging agents to human cancer cells has been shown to be an effective method for delivering such agents to eukaryotic cells in vitro. Ashley, et al., Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles. ACS nano 5:5729 (2011). Whether such bacteriophage capsids can serve a similar function for delivery of RNAi precursors to insects in the field is unknown. Effective delivery of RNAi precursors into target insects requires preventing non-specific RNA degradation, a facile route of administration, and the ability to release the RNAi precursors at the appropriate point within the target insect such that the RNAi precursors can be taken up by the insect cells and properly processed. Ideally, the RNAi precursor and delivery system must be economical and relatively simple to produce and distribute. The invention described herein satisfies all these criteria and have the added benefit of allowing rapid discovery, prototyping and commercial-scale production of new RNAi molecules.

SUMMARY OF THE INVENTION

The invention described herein uses the unique properties of VLPs (alternatively known as APSE RNA Containers, or “ARCs”), to provide an improved system for delivering long dsRNA and RNAi precursors (dsRNAi) which can be processed intra-cellularly to produce siRNA for suppressing expression of a target gene, preferably in an insect host, more preferably a Coleopteran or Lepidopteran insect pest. Of particular interest are Coleoptera such as bark beetle, elm leaf beetle, Asian longhorn beetle, death watch beetle, mountain pine beetle, coconut hispine beetle, the various corn rootworms, and the Colorado potato beetle. RNAi methods of controlling Colorado potato beetle are especially desired since these beetles have developed resistance to virtually all known insecticides.

Coleopteran insect pests are known to be susceptible to RNAi introduced via the gut, either by direct injection or by feeding on plant matter treated with RNAi precursors. Field application of naked RNAs is generally impractical due to the sensitivity of RNA to environmental specific and non-specific degradation. Furthermore, RNA is highly susceptible to degradation during the course of feeding and in transit through the insect gut. The highly stable form of VLPs serves to protect RNA borne within the VLPs in vitro. The question remains, are VLPs capable of effectively delivering RNAi precursors to the RNAi processing pathways, such as Dicer, of target insects? In particular, can VLPs protect RNAi precursors within the insect digestive tract and still deliver the intact RNAi precursor to the RNAi processing pathway of the target insect? The results presented here indicate that VLPs are extremely effective at delivering RNAi precursors into target insects.

An important advantage of producing RNAi precursors by the methods described here is that costly and complicated in vitro synthesis of RNA precursors is avoided and the desired RNA constructs can be produced by simple and economic fermentation methods. Production and purification of large quantities of RNAi precursors is facilitated by optionally coupling synthesis of the desired polynucleotide with expression of self-assembling bacteriophage capsid proteins, such as those of bacteriophage Qβ or MS2, to produce easily purified and relatively stable ARCs (VLPs), which may be applied directly to plant surfaces upon which the targeted insect pests feed, for example by spraying.

Once ingested, the ARCs may be digested in the course of transiting the insect host gut and the RNA molecules absorbed by cells lining the gut. Within the target insect cells the RNAi precursors are processed by, among other things, the host Dicer enzyme complex to generate effective RNAi forms targeted against host gene transcripts to suppress expression of essential host genes. Examples of such essential genes include, without limitation, genes involved in controlling molting or other larval development events, actin or other cellular structural components, as well as virtually any gene related to replication, transcription or translation or other fundamental process required for viability.

DETAILED DESCRIPTION OF THE INVENTION

The present invention comprises DNA sequences, which when transcribed produce RNAi precursor molecules and mRNA translated into bacteriophage coat protein, which together, are incorporated into uniquely stable VLPs. The VLPs may be purified in a form suitable for ingestion by feeding insects. Once ingested by the target insects, the VLPs transit the gut where they are then assimilated into the insect cells where the RNAi precursor is processed into a form of RNAi that suppresses expression of a target gene important to insect viability. In some embodiments, suppression of such target genes is designed to result in death of the target insect. In another embodiment, suppression of target genes is designed to produce sterile off-spring. A key feature of the VLPs is that they are stable enough to protect the encapsidated RNAi precursors from degradation by non-specific environmental agents or by insect target cell RNAse enzymes, but remain capable of introducing the RNAi precursors into the RNAi pathways in target insect cells after they are ingested.

Example sequences presented here are designed to be ligated into suitable bacterial plasmid vectors as AsiSI-NotI digested DNA fragments. Such DNA sequence fragments can be produced by direct synthesis or by sub-cloning the constituent fragments using techniques well known to those skilled in the art. The specific sequences may be modified as desired to manipulate specific restriction enzyme sites, incorporate alternative ribozyme binding sites, accommodate alternative bacteriophage pac sequences, and the specificity of the RNAi sequences may be modified to target different genes and insect hosts. Bacterial plasmid vectors containing transcriptional promoters capable of inducibly transcribing these DNA sequences include, without limitation, bacteriophage T7 gene 1 promoter, bacteriophage T5 promoter, and the bacteriophage lambda PL and PR promoters. Bacterial plasmid vectors may also contain the bacteriophage Qβ or bacteriophage MS2 capsid protein coding sequence expressed from an inducible promoter. Alternatively, such inducibly expressed capsid proteins may be present on a separate bacterial plasmid compatible with the bacterial plasmid carrying the inducible cargo RNA sequences.

The production and purification of VLPs containing RNA cargo molecules and recovery of the RNA cargo molecules are described in detail in U.S. Patent Application Publication Nos. 2013/0208221 (at least paragraphs 0013 and 0014), 2014/0302593 (at least paragraphs 0016, 0052, 0065 and 0085-0086), and as described in U.S. Pat. No. 9,181,531 (passim), the contents of each incorporated herein by reference. In addition, related methods are also described in U.S. Patent Application Publication Nos. 2010/0167981 and 2012/0046340, PCT/US2012/071419 and PCT/US2014/041111, and U.S. Pat. Nos. 5,443,969, and 6,214,982, the contents of each are also incorporated herein by reference. The VLPs produced by these methods can be processed in a number of different ways known to those skilled in the art to facilitate application of such material onto plants and for use in the field. In one embodiment the purified ARCs are further processed for spraying operations. Such processing may include spray drying, introduction of stabilizing or wetting agents, or forming an admixture of VLPs with other desired agents prior to application. Field applications may involve ground or arial spray methods or spot application.

A person skilled in the art will understand that the invention may be targeted to different genes in different insect hosts by modifying the sequences from those described in the Examples to reflect the sequences of the targeted genes in the targeted host organisms. Thus, the invention provides those skilled in the art with a tool for determining the best RNAi target for suppressing a particular gene in any given host cell and a means for producing large quantities of such RNAis. Further, the invention provides for methods of empirically determining which gene or group of genes may constitute the most effective RNAi target within a single insect or group of insects by screening the effectiveness of VLPs containing various RNAi precursors targeted to specific genes or gene combinations in such insects by combinatory cloning methods. The invention also supports methods combining VLPs effective for control of certain insects in the field with different VLPs effective for control of other insects at the point of application, in order to tailor the insect control properties to those relevant at the point of application. The different insects may be of a different order, genus or species as those targeted by the original VLPs, or may comprise RNAi resistant, or combinations of RNAi resistant populations, wherein the combination of one or more VLPs targeting different genes within the target insect population ensures that no combination of RNAi resistance is likely to occur.

In one embodiment of the present invention, a first DNA sequence within a bacterial host is transcribed to produce a first RNA molecule encoding a bacteriophage coat protein, and a second DNA sequence within said bacterial host is transcribed to produce a second RNA molecule comprising a bacteriophage pac site, followed by an antisense sequence of a target gene from an insect, followed by a unique RNA sequence capable of forming a single-stranded loop, followed by a sense sequence complementary to the antisense sequence of the target gene sequence, followed by a second bacteriophage pac site. The first RNA molecule is an mRNA which is translated by the bacterial host to produce a plurality of bacteriophage coat protein which, in combination with the second RNA molecule comprising the bacteriophage pac sequences, spontaneously forms a VLP, wherein the second RNA molecule is packaged within the VLP. VLPs are isolated and purified prior to application to the outer surfaces of a plant. Target insects feeding upon the plant ingest the VLP which in turn introduces the RNA molecule borne within the VLP into the host insect cells where it is processed by the host insect cell's endogenous RNAi pathways, resulting in RNAi-mediated suppression of gene expression of the host insect target gene. In one embodiment the insect is of the order Coleoptera. In preferred embodiments the Coleopteran insect is a Colorado potato beetle.

In another embodiment of the present invention, a first DNA sequence within a bacterial host is transcribed to produce a first RNA molecule encoding a bacteriophage coat protein, and a second DNA sequence within said bacterial host is transcribed to produce a second RNA molecule comprising a bacteriophage pac site, followed by an antisense sequence of a target gene from an insect, optionally followed by one or more bacteriophage pac sites. The first RNA molecule is an mRNA which is translated by the bacterial host to produce a plurality of bacteriophage coat protein which, in combination with the second RNA molecule comprising the bacteriophage pac sequences, spontaneously forms VLPs, wherein the second RNA molecule is packaged within the VLP. The VLPs are isolated and purified prior to application to the outer surfaces of a plant. Target insects feeding upon the plant ingest the VLP which in turn introduces the RNA molecule borne within the VLP into the host insect cells where it results in anti-sense RNA-mediated suppression of gene expression of the host insect target gene. In one embodiment the insect is of the order Coleoptera. In preferred embodiments the Coleopteran insect is a Colorado potato beetle.

In another embodiment, a series of host bacteria containing a first DNA sequence encoding a bacteriophage coat protein and different second DNA sequences encoding various RNAi sequences are isolated. Each isolated host bacteria is clonally expanded and bacterial cell line archived. A sample of each bacterial cell line is subsequently outgrown and induced to transcribe the first and second DNA sequences, the VLPS are allowed to assemble within the host bacteria and the VLPs isolated therefrom. The RNA sequences within the series of resulting VLPs each encode a different antisense and optionally a complementary sense sequence homologous to different insect target genes or on different regions of a given insect target gene or on target genes from different insect targets altogether. Each of the different VLPs produced by the series of host bacteria is fed to target insects and their ability to suppress host insect gene expression is measured, for example by scoring target insect mortality. Those VLPs producing the greatest level of RNAi-mediated suppression of gene expression represent the most effective RNA target for that particular target insect or position within a given target insect gene. Recourse to the corresponding bacterial cell line that produced each VLP allows quick identification of the corresponding target sequence or gene. Likewise, recourse to the corresponding host bacterial cell line facilitates rapid scale-up of the desired VLP for RNAi-mediated suppression of gene expression of the host insect target gene for field application or further experimental investigation. One skilled in the art will recognize that random or pseudo-random collections of complementary DNA sequences based on insect genomic sequence data or for subsets of such genomic sequence encoding likely essential genes can be screened using multiplex or automated cloning technologies.

EXAMPLES

All patents and publications mentioned in the specification are indicative of the levels of those skilled in the art to which the present disclosure pertains. All patents and publications are herein incorporated by reference to the same extent as if each individual publication was specifically and individually indicated to be incorporated by reference.

The publications discussed throughout are provided solely for their disclosure before the filing date of the present application. Nothing herein is to be construed as an admission that the invention is not entitled to antedate such disclosure by virtue of prior invention.

The following examples are included to demonstrate the disclosure. It should be appreciated by those of skill in the art that the techniques disclosed in the following examples represent techniques discovered by the inventors to function well in the practice of the disclosure. Those of skill in the art should, however, in light of the present disclosure, appreciate that many changes could be made in the disclosure and still obtain a like or similar result without departing from the spirit and scope of the disclosure, therefore all matter set forth is to be interpreted as illustrative and not in a limiting sense.

Example 1

Efficacy of Colorado Potato Beetle Control by VLPs Containing an RNAi Precursor

To determine whether VLPs containing a dsRNAi precursor targeting the β-actin gene of Colorado potato beetle (another Coleopteran insect) can suppress β-actin expression as effectively as the naked dsRNAi precursor, the following study was carried out. A 294 bp fragment of beta actin from Colorado potato beetle (Leptinotarsa decemlineata strain Freeville actin mRNA, GenBank sequence ID: gb|KJ577616.1, nucleotides 1-294) was cloned into pAPSE10136 (SEQ ID NO: 1) in such a way as to produce a transcript with sequences comprising both corresponding sense and anti-sense strands separated by a short loop of non-homologous sequence. This RNA represents a 294 bp dsRNAi precursor targeted against beta actin. The dsRNAi precursor DNA sequence was produced by PCR amplification of the 294 bp region of interest from Colorado potato beetle chromosomal DNA using primers 1174 (SEQ ID NO: 2) and 1175 (SEQ ID NO: 3), the PCR product was ligated into an intermediate plasmid by digestion of the PCR fragment and vector with restriction endonucleases AsiSI and PmeI in the sense orientation relative to one of the vector encoded T7 gene 1 promoter. The loop and anti-sense sequences were produced from the sense-strand DNA fragment by PCR amplification with primers 1213 (SEQ ID NO: 4) and 1203 (SEQ ID NO: 5). The resulting PCR fragment and the intermediate plasmid were digested with PmeI and RsrII and ligated together. The desired recombinant plasmids encoding the β-actin sense and antisense strand sequences connected by a short linker expressed from a T7 gene promoter were identified by restriction digest screening. The desired plasmid, pAPSE10216 (SEQ ID NO: 6) was transformed into chemically competent HTE115 (DE3) cells and individual clones selected for ampicillin resistant transformants.

Ampicillin resistant transformants were selected on LB agar plates containing 100 micrograms/ml ampicillin. The selected clones were subsequently grown at 37° C. in 100 ml of LB media containing ampicillin until the culture reached OD600 0.8, at which time isopropyl β-D-thiogalactopyranoside was added to a final concentration of 1 mM to induce T7 polymerase directed transcription of MS2 capsid protein and the 294 bp siRNA precursor. The induced cultures were allowed to grow for at least 4 hours post-induction to allow sufficient time for VLP formation. Cells were collected by centrifugation at 3,000 g at 4 C. Each pellet was stored at 4° C. until processing.

VLPs containing the 294 bp siRNA precursor were purified by re-suspending each pellet in approximately 10 volumes of 20 mM Tris-HCl, pH 7.0, containing 10 mM NaCl and sonicated to lyse the cells. Cell debris was removed by centrifugation at 16,000 g. Each sample was further processed by addition of Benzonase® Nuclease (Sigma Aldrich, St. Louis, Mo.) added to a final concentration of about 100 units per mL and incubated at 37° C. for two hours. Proteinase K was then added to final concentration of 150 micrograms per mL and incubated at 37° C. for an additional three hours. A saturated ammonium sulfate solution was prepared by adding ammonium sulfate to water to a final concentration of 4.1 M. The saturated ammonium sulfate was added to the enzymatically treated VLPs to a final concentration of 186 mM (approximately a 1:22 dilution) and placed on ice for two hours. Unwanted precipitate was cleared from the lysate by centrifugation at 16,000 g. A second precipitation was conducted by addition of 155 mg of dry ammonium sulfate directly to each mL of cleared lysate. Each sample was vortexed and incubated on ice for two hours. Each precipitate was spun down at 16,000 g and the solid precipitate resuspended in one tenth the original volume of 20 mM Tris-HCl, pH 7.0, containing 10 mM NaCl.

The resuspended VLPs were used to test the efficacy of encapsidated RNAi on Colorado potato beetle larvae relative to the corresponding naked RNAi. Each experimental and control cohort included 10 individual beetles undergoing 10 identical treatments. Each treatment or control sample was applied in 50 μl droplets to the surface of a 1 cm diameter potato leaf disc. Each time an application was made, a clean pipette tip was used. The treatment was allowed to dry on the leaf surface prior to being presented to the larvae. During a pretreatment period, all food was removed from the larval containers and larvae were starved for 2 hours before introduction of treated leaves to the larvae. After the starvation period, one larva was placed on each treated potato leaf in a petri dish, where it was allowed to feed on the disc until the leaf tissue was completely devoured. Larvae were allowed to feed at three separate times on treated potato leaves every two days, given a normal diet of potato leaves in the interim and monitored for mortality on a daily basis up to 21 days post-treatment. After the final treatment, live larvae were maintained on untreated potato leaves for an additional 21 days.

Table 1 summarizes the results of treating Colorado potato beetle larvae with the test RNAi administered as naked RNA or encapsidated in an ARC, produced from pAPSE10216. In addition, VLPs containing random E. coli derived RNAs with no significant homology to the Colorado potato beetle beta-actin were included as a control of general non-specific VLP toxicity. These results indicate that these VLP encapsidated RNAs are as effective in killing Colorado potato beetle larvae by suppressing expression of the essential actin gene as unencapsidated RNAi:

TABLE I
Summary of mortality rates for Colorado potato beetle
(Leptinotarsa decemlineata) larvae treated
with RNA and VLP formulations
Maximum Days to reach
Dose mortality maximum
Treatment (microgram) (%) mortality
Untreated control 0 20 15
Water control 0 20 16
VLPs with 0.5 30 19
unrelated dsRNA
VLPs with dsRNAi 0.5 100 1
precursor
dsRNAi precursor 0.5 100 1
without VLP

The naked dsRNA treated controls exhibit a high degree of mortality, consistent with the hypothesis that suppression of actin gene expression by this dsRNA results in death of beetle larvae that consume it. The cohort treated with VLPs containing the unrelated RNA exhibit little or no mortality, indicating that VLPs are not inherently toxic to the beetle larvae. The ARCs provide an effective delivery platform for RNAi active molecules, and the high level of mortality verifies that the packaging and processing steps for manufacturing VLPs does not inhibit effectiveness of the RNAi response observed from such dsRNA.

Additional experiments at doses lower than 0.5 μg, e.g. at 0.05 μg, reveal that ARCs with actin hairpin RNA have similar efficacy at lower doses to naked dsRNA at higher doses targeting the same actin sequence.

The ability of these constructs to kill Colorado potato beetle larvae confirms that these ARCs are an effective tool for introducing targeted RNAi precursors into an insect host and that these precursors can be properly processed by the host cell RNAi pathway to suppress gene expression of the target gene. These results directly demonstrate that ARCs comprising siRNA precursors are an effective delivery system for controlling Colorado potato beetle and Coleopteran insects generally.

Example 2

Efficacy of Controlling Colorado Potato Beetle Larvae by VLPs Containing Single Stranded Antisense RNA

To test whether anti-sense RNA (ssRNAi) can be effectively delivered to target insects by use of VLPs, a 294 bp DNA sequence fragment corresponding to a portion of the beta actin gene of Colorado potato beetle (Leptinotarsa decemlineata strain Freeville actin mRNA, GenBank sequence ID: gb|KJ577616.1, nucleotides 1-294) was constructed from primers 1176 (SEQ ID NO: 7) and 1177 (SEQ ID NO: 8). The primers were ordered from IDT (Integrated DNA Technologies, Inc., Coralville, Iowa) and used to amplify the beta actin sequence fragment from Colorado potato beetle genomic DNA by Accuprime PCR while adding an AsiSI restriction site 5′ of the beta actin sequence fragment and a PmeI restriction site 3′ of the beta actin sequence fragment. The resulting PCR product was digested with AsiSI and PmeI restriction endonucleases and subsequently ligated into pAPSE10136 (SEQ ID NO: 1) previously treated with AsiSI and PmeI, in the anti-sense orientation relative to the upstream T7 promoter, to form pAPSE10190 (SEQ ID NO: 9). This plasmid allows the β-actin antisense strand RNA (ssRNAi) to be packaged in VLPs at high efficiency by incorporating bacteriophage pac sites into the transcript. Chemically competent HTE115 (DE3) cells were transformed and VLPs were produced by fermentation and subsequently isolated as described in Example 2. The VLPs were then tested for the ability to suppress Colorado potato beetle larvae as described in Example 2. Table 2 summarizes the results:

TABLE 2
Summary of mortality rates of Colorado potato beetle
(Leptinotarsa decemlineata) larvae treated with
single stranded anti-sense RNA and VLP formulations.
Maximum Days to reach
Dose mortality maximum
Treatment (microgram) (%) mortality
Untreated control 0 20 15
Water control 0 20 16
VLPs with no ssRNAi 0.5 30 19
VLPs with ssRNAi 0.5 100 1
ssRNAi without VLP 0.5 100 8

These data indicate that VLPs improve the efficacy of single-stranded anti-sense RNA directed to suppressing expression of the essential beta-actin gene in killing Colorado potato beetle larvae. Further, these results indicate that these VLPs are even more effective in killing Colorado potato beetle larvae by suppressing expression of the essential actin gene than the corresponding unencapsidated RNAi. These results suggest that ARCs comprising antisense ssRNA also serve as an effective delivery system for controlling Coleopteran insects generally, and Colorado potato beetle specifically.

SEQUENCES
SEQ ID
NO: Sequence Description
1 ttctcatgtt tgacagctta Plasmid
tcatcgataa gctttaatgc pAPSE
ggtagtttat cacagttaaa 10136
ttgctaacgc agtcaggcac
cgtgtatgaa atctaacaat
gcgctcatcg tcatcctcgg
caccgtcacc ctggatgctg
taggcatagg cttggttatg
ccggtactgc cgggcctctt
gcgggatgaa ttcagatctc
gatcccgcga aattaatacg
actcactata gggagaccac
aacggtttcc ctctagatca
caagtttgta caaaaaagca
ggctaagaag gagatataca
tacgccggcc attcaaacat
gaggattacc catgtattta
aatacccatg tccaggcgcg
ctccgcgatc gcacgcggac
aactactaca gggtttaaac
ctttcggatt ataacatcac
atctaggcgc gcctgacgat
caaccatacc agacggaccg
aatacccggt ctgaacgagg
gcggccgcgg tacccaagaa
gtacttagag ttaattaagg
agttcaaaca tgaggatcac
ccatgtcgaa gctcccacac
cctagcataa ccccttgggg
cctctaaacg ggtcttgagg
ggttttttgc tgaaaggagg
aactatatcc ggatatccac
aggacgggtg tggtcgccat
gatcgcgtag tcgatagtgg
ctccaagtag cgaagcgagc
aggactgggc ggcgggcatg
catcgtccat tccgacagca
tcgccagtca ctatggcgtg
ctgctagcgc tatatgcgtt
gatgcaattt ctatgcgcac
ccgttctcgg agcactgtcc
gaccgctttg gccgccgccc
agtcctgctc gcttcgctac
ttggagccac tatcgactac
gcgatcatgg cgaccacacc
cgtcctgtgg atccagatct
cgatcccgcg aaattaatac
gactcactat agggagacca
caacggtttc cctctagatc
acaagtttgt acaaaaaagc
aggctaagaa ggagatatac
atatggcgtc taactttacc
caattcgttc tggttgataa
cggcggtacg ggtgacgtta
ccgtagctcc gtccaacttc
gccaacggtg ttgcggaatg
gattagctct aacagccgct
ctcaggccta caaagtcacg
tgctccgttc gtcagtctag
cgcgcagaat cgcaaataca
ccatcaaagt tgaagtaccg
aaagtcgcaa cgcagaccgt
aggcggcgta gaactcccag
ttgcggcctg gcgctcttac
ctcaacatgg aactgactat
tccgattttt gcgacgaact
ccgactgcga actgattgtt
aaggcaatgc agggcctgct
gaaagacggt aatccgatcc
catctgcaat cgctgctaac
tctggcattt actaataagc
ggacgcgctg ccaccgctga
gcaataacta gcataacccc
ttggggcctc taaacgggtc
ttgaggggtt ttttgctgaa
aggaggaact atatccggca
tgcaccattc cttgcggcgg
cggtgctcaa cggcctcaac
ctactactgg gctgcttcct
aatgcaggag tcgcataagg
gagagcgtcg accgatgccc
ttgagagcct tcaacccagt
cagctccttc cggtgggcgc
ggggcatgac tatcgtcgcc
gcacttatga ctgtcttctt
tatcatgcaa ctcgtaggac
aggtgccggc agcgctctgg
gtcattttcg gcgaggaccg
ctttcgctgg agcgcgacga
tgatcggcct gtcgcttgcg
gtattcggaa tcttgcacgc
cctcgctcaa gccttcgtca
ctggtcccgc caccaaacgt
ttcggcgaga agcaggccat
tatcgccggc atggcggccg
acgcgctggg ctacgtcttg
ctggcgttcg cgacgcgagg
ctggatggcc ttccccatta
tgattcttct cgcttccggc
ggcatcggga tgcccgcgtt
gcaggccatg ctgtccaggc
aggtagatga cgaccatcag
ggacagcttc aaggatcgct
cgcggctctt accagcctaa
cttcgatcat tggaccgctg
atcgtcacgg cgatttatgc
cgcctcggcg agcacatgga
acgggttggc atggattgta
ggcgccgccc tataccttgt
ctgcctcccc gcgttgcgtc
gcggtgcatg gagccgggcc
acctcgacct gaatggaagc
cggcggcacc tcgctaacgg
attcaccact ccaagaattg
gagccaatca attcttgcgg
agaactgtga atgcgcaaac
caacccttgg cagaacatat
ccatcgcgtc cgccatctcc
agcagccgca cgcggcgcat
ctcgggcagc gttgggtcct
ggccacgggt gcgcatgatc
gtgctcctgt cgttgaggac
ccggctaggc tggcggggtt
gccttactgg ttagcagaat
gaatcaccga tacgcgagcg
aacgtgaagc gactgctgct
gcaaaacgtc tgcgacctga
gcaacaacat gaatggtctt
cggtttccgt gtttcgtaaa
gtctggaaac gcggaagtca
gcgccctgca ccattatgtt
ccggatctgc atcgcaggat
gctgctggct accctgtgga
acacctacat ctgtattaac
gaagcgctgg cattgaccct
gagtgatttt tctctggtcc
cgccgcatcc ataccgccag
ttgtttaccc tcacaacgtt
ccagtaaccg ggcatgttca
tcatcagtaa cccgtatcgt
gagcatcctc tctcgtttca
tcggtatcat tacccccatg
aacagaaatc ccccttacac
ggaggcatca gtgaccaaac
aggaaaaaac cgcccttaac
atggcccgct ttatcagaag
ccagacatta acgcttctgg
agaaactcaa cgagctggac
gcggatgaac aggcagacat
ctgtgaatcg cttcacgacc
acgctgatga gctttaccgc
agctgcctcg cgcgtttcgg
tgatgacggt gaaaacctct
gacacatgca gctcccggag
acggtcacag cttgtctgta
agcggatgcc gggagcagac
aagcccgtca gggcgcgtca
gcgggtgttg gcgggtgtcg
gggcgcagcc atgacccagt
cacgtagcga tagcggagtg
tatactggct taactatgcg
gcatcagagc agattgtact
gagagtgcac catatgcggt
gtgaaatacc gcacagatgc
gtaaggagaa aataccgcat
caggcgctct tccgcttcct
cgctcactga ctcgctgcgc
tcggtcgttc ggctgcggcg
agcggtatca gctcactcaa
aggcggtaat acggttatcc
acagaatcag gggataacgc
aggaaagaac atgtgagcaa
aaggccagca aaaggccagg
aaccgtaaaa aggccgcgtt
gctggcgttt ttccataggc
tccgcccccc tgacgagcat
cacaaaaatc gacgctcaag
tcagaggtgg cgaaacccga
caggactata aagataccag
gcgtttcccc ctggaagctc
cctcgtgcgc tctcctgttc
cgaccctgcc gcttaccgga
tacctgtccg cctttctccc
ttcgggaagc gtggcgcttt
ctcatagctc acgctgtagg
tatctcagtt cggtgtaggt
cgttcgctcc aagctgggct
gtgtgcacga accccccgtt
cagcccgacc gctgcgcctt
atccggtaac tatcgtcttg
agtccaaccc ggtaagacac
gacttatcgc cactggcagc
agccactggt aacaggatta
gcagagcgag gtatgtaggc
ggtgctacag agttcttgaa
gtggtggcct aactacggct
acactagaag gacagtattt
ggtatctgcg ctctgctgaa
gccagttacc ttcggaaaaa
gagttggtag ctcttgatcc
ggcaaacaaa ccaccgctgg
tagcggtggt ttttttgttt
gcaagcagca gattacgcgc
agaaaaaaag gatctcaaga
agatcctttg atcttttcta
cggggtctga cgctcagtgg
aacgaaaact cacgttaagg
gattttggtc atgagattat
caaaaaggat cttcacctag
atccttttaa attaaaaatg
aagttttaaa tcaatctaaa
gtatatatga gtaaacttgg
tctgacagtt accaatgctt
aatcagtgag gcacctatct
cagcgatctg tctatttcgt
tcatccatag ttgcctgact
ccccgtcgtg tagataacta
cgatacggga gggcttacca
tctggcccca gtgctgcaat
gataccgcga gacccacgct
caccggctcc agatttatca
gcaataaacc agccagccgg
aagggccgag cgcagaagtg
gtcctgcaac tttatccgcc
tccatccagt ctattaattg
ttgccgggaa gctagagtaa
gtagttcgcc agttaatagt
ttgcgcaacg ttgttgccat
tgctgcaggc atcgtggtgt
cacgctcgtc gtttggtatg
gcttcattca gctccggttc
ccaacgatca aggcgagtta
catgatcccc catgttgtgc
aaaaaagcgg ttagctcctt
cggtcctccg atcgttgtca
gaagtaagtt ggccgcagtg
ttatcactca tggttatggc
agcactgcat aattctctta
ctgtcatgcc atccgtaaga
tgcttttctg tgactggtga
gtactcaacc aagtcattct
gagaatagtg tatgcggcga
ccgagttgct cttgcccggc
gtcaacacgg gataataccg
cgccacatag cagaacttta
aaagtgctca tcattggaaa
acgttcttcg gggcgaaaac
tctcaaggat cttaccgctg
ttgagatcca gttcgatgta
acccactcgt gcacccaact
gatcttcagc atcttttact
ttcaccagcg tttctgggtg
agcaaaaaca ggaaggcaaa
atgccgcaaa aaagggaata
agggcgacac ggaaatgttg
aatactcata ctcttccttt
ttcaatatta ttgaagcatt
tatcagggtt attgtctcat
gagcggatac atatttgaat
gtatttagaa aaataaacaa
ataggggttc cgcgcacatt
tccccgaaaa gtgccacctg
acgtctaaga aaccattatt
atcatgacat taacctataa
aaataggcgt atcacgaggc
cctttcgtct tcaagaa
2 cattggcgat cgcgcacgag PCR primer
gtttttctgt ctagtgagca 1174
g
3 cattggttta aactcatccc PCR primer
agttggtgat gataccg 1175
4 cattggttta aaccctctag CR primer
ctgctttaca aagtactggt 1213
tccctttcca gcgggatgct
ttatctaaac gcaatgagag
aggtattcct caggccacat
cgcttcctag ttccgctggg
atccatcgtt ggcggccgaa
gccgccattc catagtgagt
tctggcgcgc ctcatcccag
ttggtgatga taccgtgttc
5 cattgcggtc cggcacgagg PCR primer
tttttctgtc tagtgag 1203
6 ttctcatgtt tgacagctta plasmid
tcatcgataa gctttaatgc pAPSE
ggtagtttat cacagttaaa 10216
ttgctaacgc agtcaggcac
cgtgtatgaa atctaacaat
gcgctcatcg tcatcctcgg
caccgtcacc ctggatgctg
taggcatagg cttggttatg
ccggtactgc cgggcctctt
gcgggatgaa ttcagatctc
gatcccgcga aattaatacg
actcactata gggagaccac
aacggtttcc ctctagatca
caagtttgta caaaaaagca
ggctaagaag gagatataca
tacgccggcc attcaaacat
gaggattacc catgtattta
aatacccatg tccaggcgcg
ctccgcgatc gcgcacgagg
tttttctgtc tagtgagcag
tgtccaacct caaaagacaa
catgtgtgac gacgatgtag
cggctcttgt cgtagacaat
ggatccggta tgtgcaaagc
cggtttcgca ggagatgacg
caccccgtgc cgtcttcccc
tcgatcgtcg gtcgcccaag
gcatcaagga gtcatggtcg
gtatgggaca aaaggactca
tacgtaggag atgaagccca
aagcaaaaga ggtatcctca
ccctgaaata ccccatcgaa
cacggtatca tcaccaactg
ggatgagttt aaaccctcta
gctgctttac aaagtactgg
ttccctttcc agcgggatgc
tttatctaaa cgcaatgaga
gaggtattcc tcaggccaca
tcgcttccta gttccgctgg
gatccatcgt tggcggccga
agccgccatt ccatagtgag
ttctggcgcg cctcatccca
gttggtgatg ataccgtgtt
cgatggggta tttcagggtg
aggatacctc ttttgctttg
ggcttcatct cctacgtatg
agtccttttg tcccataccg
accatgactc cttgatgcct
tgggcgaccg acgatcgagg
ggaagacggc acggggtgcg
tcatctcctg cgaaaccggc
tttgcacata ccggatccat
tgtctacgac aagagccgct
acatcgtcgt cacacatgtt
gtcttttgag gttggacact
gctcactaga cagaaaaacc
tcgtgccgga ccgaataccc
ggtctgaacg agggcggccg
cggtacccaa gaagtactta
gagttaatta aggagttcaa
acatgaggat cacccatgtc
gaagctccca caccctagca
taaccccttg gggcctctaa
acgggtcttg aggggttttt
tgctgaaagg aggaactata
tccggatatc cacaggacgg
gtgtggtcgc catgatcgcg
tagtcgatag tggctccaag
tagcgaagcg agcaggactg
ggcggcgggc atgcatcgtc
cattccgaca gcatcgccag
tcactatggc gtgctgctag
cgctatatgc gttgatgcaa
tttctatgcg cacccgttct
cggagcactg tccgaccgct
ttggccgccg cccagtcctg
ctcgcttcgc tacttggagc
cactatcgac tacgcgatca
tggcgaccac acccgtcctg
tggatccaga tctcgatccc
gcgaaattaa tacgactcac
tatagggaga ccacaacggt
ttccctctag atcacaagtt
tgtacaaaaa agcaggctaa
gaaggagata tacatatggc
gtctaacttt acccaattcg
ttctggttga taacggcggt
acgggtgacg ttaccgtagc
tccgtccaac ttcgccaacg
gtgttgcgga atggattagc
tctaacagcc gctctcaggc
ctacaaagtc acgtgctccg
ttcgtcagtc tagcgcgcag
aatcgcaaat acaccatcaa
agttgaagta ccgaaagtcg
caacgcagac cgtaggcggc
gtagaactcc cagttgcggc
ctggcgctct tacctcaaca
tggaactgac tattccgatt
tttgcgacga actccgactg
cgaactgatt gttaaggcaa
tgcagggcct gctgaaagac
ggtaatccga tcccatctgc
aatcgctgct aactctggca
tttactaata agcggacgcg
ctgccaccgc tgagcaataa
ctagcataac cccttggggc
ctctaaacgg gtcttgaggg
gttttttgct gaaaggagga
actatatccg gcatgcacca
ttccttgcgg cggcggtgct
caacggcctc aacctactac
tgggctgctt cctaatgcag
gagtcgcata agggagagcg
tcgaccgatg cccttgagag
ccttcaaccc agtcagctcc
ttccggtggg cgcggggcat
gactatcgtc gccgcactta
tgactgtctt ctttatcatg
caactcgtag gacaggtgcc
ggcagcgctc tgggtcattt
tcggcgagga ccgctttcgc
tggagcgcga cgatgatcgg
cctgtcgctt gcggtattcg
gaatcttgca cgccctcgct
caagccttcg tcactggtcc
cgccaccaaa cgtttcggcg
agaagcaggc cattatcgcc
ggcatggcgg ccgacgcgct
gggctacgtc ttgctggcgt
tcgcgacgcg aggctggatg
gccttcccca ttatgattct
tctcgcttcc ggcggcatcg
ggatgcccgc gttgcaggcc
atgctgtcca ggcaggtaga
tgacgaccat cagggacagc
ttcaaggatc gctcgcggct
cttaccagcc taacttcgat
cattggaccg ctgatcgtca
cggcgattta tgccgcctcg
gcgagcacat ggaacgggtt
ggcatggatt gtaggcgccg
ccctatacct tgtctgcctc
cccgcgttgc gtcgcggtgc
atggagccgg gccacctcga
cctgaatgga agccggcggc
acctcgctaa cggattcacc
actccaagaa ttggagccaa
tcaattcttg cggagaactg
tgaatgcgca aaccaaccct
tggcagaaca tatccatcgc
gtccgccatc tccagcagcc
gcacgcggcg catctcgggc
agcgttgggt cctggccacg
ggtgcgcatg atcgtgctcc
tgtcgttgag gacccggcta
ggctggcggg gttgccttac
tggttagcag aatgaatcac
cgatacgcga gcgaacgtga
agcgactgct gctgcaaaac
gtctgcgacc tgagcaacaa
catgaatggt cttcggtttc
cgtgtttcgt aaagtctgga
aacgcggaag tcagcgccct
gcaccattat gttccggatc
tgcatcgcag gatgctgctg
gctaccctgt ggaacaccta
catctgtatt aacgaagcgc
tggcattgac cctgagtgat
ttttctctgg tcccgccgca
tccataccgc cagttgttta
ccctcacaac gttccagtaa
ccgggcatgt tcatcatcag
taacccgtat cgtgagcatc
ctctctcgtt tcatcggtat
cattaccccc atgaacagaa
atccccctta cacggaggca
tcagtgacca aacaggaaaa
aaccgccctt aacatggccc
gctttatcag aagccagaca
ttaacgcttc tggagaaact
caacgagctg gacgcggatg
aacaggcaga catctgtgaa
tcgcttcacg accacgctga
tgagctttac cgcagctgcc
tcgcgcgttt cggtgatgac
ggtgaaaacc tctgacacat
gcagctcccg gagacggtca
cagcttgtct gtaagcggat
gccgggagca gacaagcccg
tcagggcgcg tcagcgggtg
ttggcgggtg tcggggcgca
gccatgaccc agtcacgtag
cgatagcgga gtgtatactg
gcttaactat gcggcatcag
agcagattgt actgagagtg
caccatatgc ggtgtgaaat
accgcacaga tgcgtaagga
gaaaataccg catcaggcgc
tcttccgctt cctcgctcac
tgactcgctg cgctcggtcg
ttcggctgcg gcgagcggta
tcagctcact caaaggcggt
aatacggtta tccacagaat
caggggataa cgcaggaaag
aacatgtgag caaaaggcca
gcaaaaggcc aggaaccgta
aaaaggccgc gttgctggcg
tttttccata ggctccgccc
ccctgacgag catcacaaaa
atcgacgctc aagtcagagg
tggcgaaacc cgacaggact
ataaagatac caggcgtttc
cccctggaag ctccctcgtg
cgctctcctg ttccgaccct
gccgcttacc ggatacctgt
ccgcctttct cccttcggga
agcgtggcgc tttctcatag
ctcacgctgt aggtatctca
gttcggtgta ggtcgttcgc
tccaagctgg gctgtgtgca
cgaacccccc gttcagcccg
accgctgcgc cttatccggt
aactatcgtc ttgagtccaa
cccggtaaga cacgacttat
cgccactggc agcagccact
ggtaacagga ttagcagagc
gaggtatgta ggcggtgcta
cagagttctt gaagtggtgg
cctaactacg gctacactag
aaggacagta tttggtatct
gcgctctgct gaagccagtt
accttcggaa aaagagttgg
tagctcttga tccggcaaac
aaaccaccgc tggtagcggt
ggtttttttg tttgcaagca
gcagattacg cgcagaaaaa
aaggatctca agaagatcct
ttgatctttt ctacggggtc
tgacgctcag tggaacgaaa
actcacgtta agggattttg
gtcatgagat tatcaaaaag
gatcttcacc tagatccttt
taaattaaaa atgaagtttt
aaatcaatct aaagtatata
tgagtaaact tggtctgaca
gttaccaatg cttaatcagt
gaggcaccta tctcagcgat
ctgtctattt cgttcatcca
tagttgcctg actccccgtc
gtgtagataa ctacgatacg
ggagggctta ccatctggcc
ccagtgctgc aatgataccg
cgagacccac gctcaccggc
tccagattta tcagcaataa
accagccagc cggaagggcc
gagcgcagaa gtggtcctgc
aactttatcc gcctccatcc
agtctattaa ttgttgccgg
gaagctagag taagtagttc
gccagttaat agtttgcgca
acgttgttgc cattgctgca
ggcatcgtgg tgtcacgctc
gtcgtttggt atggcttcat
tcagctccgg ttcccaacga
tcaaggcgag ttacatgatc
ccccatgttg tgcaaaaaag
cggttagctc cttcggtcct
ccgatcgttg tcagaagtaa
gttggccgca gtgttatcac
tcatggttat ggcagcactg
cataattctc ttactgtcat
gccatccgta agatgctttt
ctgtgactgg tgagtactca
accaagtcat tctgagaata
gtgtatgcgg cgaccgagtt
gctcttgccc ggcgtcaaca
cgggataata ccgcgccaca
tagcagaact ttaaaagtgc
tcatcattgg aaaacgttct
tcggggcgaa aactctcaag
gatcttaccg ctgttgagat
ccagttcgat gtaacccact
cgtgcaccca actgatcttc
agcatctttt actttcacca
gcgtttctgg gtgagcaaaa
acaggaaggc aaaatgccgc
aaaaaaggga ataagggcga
cacggaaatg ttgaatactc
atactcttcc tttttcaata
ttattgaagc atttatcagg
gttattgtct catgagcgga
tacatatttg aatgtattta
gaaaaataaa caaatagggg
ttccgcgcac atttccccga
aaagtgccac ctgacgtcta
agaaaccatt attatcatga
cattaaccta taaaaatagg
cgtatcacga ggccctttcg
tcttcaagaa
7 cattggcgat cgctcatccc PCR primer
agttggtgat gataccg 1176
8 cattggttta aacgcacgag PCR primer
gtttttctgt ctagtgag 1177
9 ttctcatgtt tgacagctta plasmid
tcatcgataa gctttaatgc pAPSE
ggtagtttat cacagttaaa 10190
ttgctaacgc agtcaggcac
cgtgtatgaa atctaacaat
gcgctcatcg tcatcctcgg
caccgtcacc ctggatgctg
taggcatagg cttggttatg
ccggtactgc cgggcctctt
gcgggatgaa ttcagatctc
gatcccgcga aattaatacg
actcactata gggagaccac
aacggtttcc ctctagatca
caagtttgta caaaaaagca
ggctaagaag gagatataca
tacgccggcc attcaaacat
gaggattacc catgtattta
aatacccatg tccaggcgcg
ctccgcgatc gctcatccca
gttggtgatg ataccgtgtt
cgatggggta tttcagggtg
aggatacctc ttttgctttg
ggcttcatct cctacgtatg
agtccttttg tcccataccg
accatgactc cttgatgcct
tgggcgaccg acgatcgagg
ggaagacggc acggggtgcg
tcatctcctg cgaaaccggc
tttgcacata ccggatccat
tgtctacgac aagagccgct
acatcgtcgt cacacatgtt
gtcttttgag gttggacact
gctcactaga cagaaaaacc
tcgtgcgttt aaacctttcg
gattataaca tcacatctag
gcgcgcctga cgatcaacca
taccagacgg accgaatacc
cggtctgaac gagggcggcc
gcggtaccca agaagtactt
agagttaatt aaggagttca
aacatgagga tcacccatgt
cgaagctccc acaccctagc
ataacccctt ggggcctcta
aacgggtctt gaggggtttt
ttgctgaaag gaggaactat
atccggatat ccacaggacg
ggtgtggtcg ccatgatcgc
gtagtcgata gtggctccaa
gtagcgaagc gagcaggact
gggcggcggg catgcatcgt
ccattccgac agcatcgcca
gtcactatgg cgtgctgcta
gcgctatatg cgttgatgca
atttctatgc gcacccgttc
tcggagcact gtccgaccgc
tttggccgcc gcccagtcct
gctcgcttcg ctacttggag
ccactatcga ctacgcgatc
atggcgacca cacccgtcct
gtggatccag atctcgatcc
cgcgaaatta atacgactca
ctatagggag accacaacgg
tttccctcta gatcacaagt
ttgtacaaaa aagcaggcta
agaaggagat atacatatgg
cgtctaactt tacccaattc
gttctggttg ataacggcgg
tacgggtgac gttaccgtag
ctccgtccaa cttcgccaac
ggtgttgcgg aatggattag
ctctaacagc cgctctcagg
cctacaaagt cacgtgctcc
gttcgtcagt ctagcgcgca
gaatcgcaaa tacaccatca
aagttgaagt accgaaagtc
gcaacgcaga ccgtaggcgg
cgtagaactc ccagttgcgg
cctggcgctc ttacctcaac
atggaactga ctattccgat
ttttgcgacg aactccgact
gcgaactgat tgttaaggca
atgcagggcc tgctgaaaga
cggtaatccg atcccatctg
caatcgctgc taactctggc
atttactaat aagcggacgc
gctgccaccg ctgagcaata
actagcataa ccccttgggg
cctctaaacg ggtcttgagg
ggttttttgc tgaaaggagg
aactatatcc ggcatgcacc
attccttgcg gcggcggtgc
tcaacggcct caacctacta
ctgggctgct tcctaatgca
ggagtcgcat aagggagagc
gtcgaccgat gcccttgaga
gccttcaacc cagtcagctc
cttccggtgg gcgcggggca
tgactatcgt cgccgcactt
atgactgtct tctttatcat
gcaactcgta ggacaggtgc
cggcagcgct ctgggtcatt
ttcggcgagg accgctttcg
ctggagcgcg acgatgatcg
gcctgtcgct tgcggtattc
ggaatcttgc acgccctcgc
tcaagccttc gtcactggtc
ccgccaccaa acgtttcggc
gagaagcagg ccattatcgc
cggcatggcg gccgacgcgc
tgggctacgt cttgctggcg
ttcgcgacgc gaggctggat
ggccttcccc attatgattc
ttctcgcttc cggcggcatc
gggatgcccg cgttgcaggc
catgctgtcc aggcaggtag
atgacgacca tcagggacag
cttcaaggat cgctcgcggc
tcttaccagc ctaacttcga
tcattggacc gctgatcgtc
acggcgattt atgccgcctc
ggcgagcaca tggaacgggt
tggcatggat tgtaggcgcc
gccctatacc ttgtctgcct
ccccgcgttg cgtcgcggtg
catggagccg ggccacctcg
acctgaatgg aagccggcgg
cacctcgcta acggattcac
cactccaaga attggagcca
atcaattctt gcggagaact
gtgaatgcgc aaaccaaccc
ttggcagaac atatccatcg
cgtccgccat ctccagcagc
cgcacgcggc gcatctcggg
cagcgttggg tcctggccac
gggtgcgcat gatcgtgctc
ctgtcgttga ggacccggct
aggctggcgg ggttgcctta
ctggttagca gaatgaatca
ccgatacgcg agcgaacgtg
aagcgactgc tgctgcaaaa
cgtctgcgac ctgagcaaca
acatgaatgg tcttcggttt
ccgtgtttcg taaagtctgg
aaacgcggaa gtcagcgccc
tgcaccatta tgttccggat
ctgcatcgca ggatgctgct
ggctaccctg tggaacacct
acatctgtat taacgaagcg
ctggcattga ccctgagtga
tttttctctg gtcccgccgc
atccataccg ccagttgttt
accctcacaa cgttccagta
accgggcatg ttcatcatca
gtaacccgta tcgtgagcat
cctctctcgt ttcatcggta
tcattacccc catgaacaga
aatccccctt acacggaggc
atcagtgacc aaacaggaaa
aaaccgccct taacatggcc
cgctttatca gaagccagac
attaacgctt ctggagaaac
tcaacgagct ggacgcggat
gaacaggcag acatctgtga
atcgcttcac gaccacgctg
atgagcttta ccgcagctgc
ctcgcgcgtt tcggtgatga
cggtgaaaac ctctgacaca
tgcagctccc ggagacggtc
acagcttgtc tgtaagcgga
tgccgggagc agacaagccc
gtcagggcgc gtcagcgggt
gttggcgggt gtcggggcgc
agccatgacc cagtcacgta
gcgatagcgg agtgtatact
ggcttaacta tgcggcatca
gagcagattg tactgagagt
gcaccatatg cggtgtgaaa
taccgcacag atgcgtaagg
agaaaatacc gcatcaggcg
ctcttccgct tcctcgctca
ctgactcgct gcgctcggtc
gttcggctgc ggcgagcggt
atcagctcac tcaaaggcgg
taatacggtt atccacagaa
tcaggggata acgcaggaaa
gaacatgtga gcaaaaggcc
agcaaaaggc caggaaccgt
aaaaaggccg cgttgctggc
gtttttccat aggctccgcc
cccctgacga gcatcacaaa
aatcgacgct caagtcagag
gtggcgaaac ccgacaggac
tataaagata ccaggcgttt
ccccctggaa gctccctcgt
gcgctctcct gttccgaccc
tgccgcttac cggatacctg
tccgcctttc tcccttcggg
aagcgtggcg ctttctcata
gctcacgctg taggtatctc
agttcggtgt aggtcgttcg
ctccaagctg ggctgtgtgc
acgaaccccc cgttcagccc
gaccgctgcg ccttatccgg
taactatcgt cttgagtcca
acccggtaag acacgactta
tcgccactgg cagcagccac
tggtaacagg attagcagag
cgaggtatgt aggcggtgct
acagagttct tgaagtggtg
gcctaactac ggctacacta
gaaggacagt atttggtatc
tgcgctctgc tgaagccagt
taccttcgga aaaagagttg
gtagctcttg atccggcaaa
caaaccaccg ctggtagcgg
tggttttttt gtttgcaagc
agcagattac gcgcagaaaa
aaaggatctc aagaagatcc
tttgatcttt tctacggggt
ctgacgctca gtggaacgaa
aactcacgtt aagggatttt
ggtcatgaga ttatcaaaaa
ggatcttcac ctagatcctt
ttaaattaaa aatgaagttt
taaatcaatc taaagtatat
atgagtaaac ttggtctgac
agttaccaat gcttaatcag
tgaggcacct atctcagcga
tctgtctatt tcgttcatcc
atagttgcct gactccccgt
cgtgtagata actacgatac
gggagggctt accatctggc
cccagtgctg caatgatacc
gcgagaccca cgctcaccgg
ctccagattt atcagcaata
aaccagccag ccggaagggc
cgagcgcaga agtggtcctg
caactttatc cgcctccatc
cagtctatta attgttgccg
ggaagctaga gtaagtagtt
cgccagttaa tagtttgcgc
aacgttgttg ccattgctgc
aggcatcgtg gtgtcacgct
cgtcgtttgg tatggcttca
ttcagctccg gttcccaacg
atcaaggcga gttacatgat
cccccatgtt gtgcaaaaaa
gcggttagct ccttcggtcc
tccgatcgtt gtcagaagta
agttggccgc agtgttatca
ctcatggtta tggcagcact
gcataattct cttactgtca
tgccatccgt aagatgcttt
tctgtgactg gtgagtactc
aaccaagtca ttctgagaat
agtgtatgcg gcgaccgagt
tgctcttgcc cggcgtcaac
acgggataat accgcgccac
atagcagaac tttaaaagtg
ctcatcattg gaaaacgttc
ttcggggcga aaactctcaa
ggatcttacc gctgttgaga
tccagttcga tgtaacccac
tcgtgcaccc aactgatctt
cagcatcttt tactttcacc
agcgtttctg ggtgagcaaa
aacaggaagg caaaatgccg
caaaaaaggg aataagggcg
acacggaaat gttgaatact
catactcttc ctttttcaat
attattgaag catttatcag
ggttattgtc tcatgagcgg
atacatattt gaatgtattt
agaaaaataa acaaataggg
gttccgcgca catttccccg
aaaagtgcca cctgacgtct
aagaaaccat tattatcatg
acattaacct ataaaaatag
gcgtatcacg aggccctttc
gtcttcaaga a

Claims

What is claimed is:

1. A virus-like-particle (VLP) for controlling target insects, the VLP comprising a bacteriophage capsid protein encapsidating an RNA transcript comprising at least one bacteriophage pac sequence coupled to an RNAi precursor sequence targeted against a gene transcript of the insect to suppress expression of the gene in the insect.

2. The VLP of claim 1, wherein the bacteriophage capsid protein derives from a levivirus.

3. The VLP of claim 2, wherein the levivirus is Qβ.

4. The VLP of claim 2, wherein the levivirus is MS2.

5. The VLP of claim 1, wherein the RNAi precursor forms an siRNA.

6. The VLP of claim 1, wherein the RNAi precursor forms an antisense RNA.

7. The VLP of claim 1, wherein the RNA transcript comprises a first bacteriophage pac site, followed by an antisense sequence of the gene, followed by an RNA sequence capable of forming a single-stranded loop, followed by a sense sequence complementary to the antisense sequence of the gene, followed by a second bacteriophage pac site.

8. The VLP of claim 1, wherein the RNA transcript comprises a bacteriophage pac site, followed by an antisense sequence of the gene, optionally followed by one or more bacteriophage pac sites.

9. The VLP of claim 1, wherein the gene is an essential gene.

10. The VLP of claim 9, wherein the essential gene is a gene controlling a larval development event, a gene encoding cellular structural components, or a gene encoding nucleic acid replication, transcription, or translation.

11. The VLP of claim 9, wherein suppression of the essential gene results in death of the insect.

12. The VLP of claim 9, wherein suppression of the essential gene results in the production of sterile off-spring.

13. The VLP of claim 9, wherein the essential gene encodes β-actin.

14. The VLP of claim 1, wherein the target insect is a Lepidopteran insect.

15. The VLP of claim 1, wherein the target insect is a Coleopteran insect.

16. The VLP of claim 15, wherein the Coleopteran insect is bark beetle, elm leaf beetle, Asian longhorn beetle, death watch beetle, mountain pine beetle, coconut hispine beetle, a corn rootworm, or Colorado potato beetle.

17. The VLP of claim 1, wherein the target insect is Colorado potato beetle.

18. The VLP of claim 17, wherein the gene encodes β-actin, and the RNAi precursor sequence is encoded by nucleotides 314-1219 of SEQ ID NO: 6.

19. The VLP of claim 17, wherein the gene encodes β-actin, and the RNAi precursor sequence is encoded by nucleotides 317-820 of SEQ ID NO: 9.

20. A combination of two or more VLPs of claim 1, wherein each RNAi precursor sequence is targeted against a different gene transcript of the insect to suppress expression of each targeted gene in the insect.

Resources

Sources:

Similar patent applications:

Recent applications in this class:

Recent applications for this Assignee: